Open AccessHepatotoxicity due to first-line anti-tuberculosis drugs: a five-year experience in a Taiwan medical centre
Author(s) -
ChinChung Shu,
ChihHsin Lee,
MingChe Lee,
JannYuan Wang,
ChongJen Yu,
LiNa Lee
Publication year - 2013
Publication title -
the international journal of tuberculosis and lung disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.103
H-Index - 110
eISSN - 1815-7920
pISSN - 1027-3719
DOI - 10.5588/ijtld.12.0782
Subject(s) - medicine , pyrazinamide , tuberculosis , rifampicin , regimen , gastroenterology , asymptomatic , incidence (geometry) , isoniazid , liver disease , surgery , pathology , physics , optics
Hepatotoxicity with first-line drugs, a major complication of anti-tuberculosis treatment, has not been studied by time-dependent analysis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom